Stoke Therapeutics, Inc. (STOK)
34.00
+0.81
(+2.44%)
USD |
NASDAQ |
Mar 16, 16:00
33.11
-0.89
(-2.62%)
After-Hours: 20:00
Stoke Therapeutics Market Cap : 1.942B for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 26.89B |
| Krystal Biotech, Inc. | 7.310B |
| Scholar Rock Holding Corp. | 4.626B |
| Vertex Pharmaceuticals, Inc. | 118.40B |
| Zymeworks, Inc. | 1.755B |
Market Cap Related Metrics
| PE Ratio | 51.52 |
| PS Ratio | 9.648 |
| Price to Book Value | 6.303 |
| Price to Free Cash Flow | 37.88 |
| Price | 34.00 |
| Earnings Yield | 1.94% |
| Operating PE Ratio | 72.95 |
| Normalized PE Ratio | 51.52 |